Successfully treating and reversing the effects of multiple sclerosis (MS), may be possible one day using a drug originally developed to treat chronic pain, says Professor Linda Watkins of the University of Colorado at Boulder.
Watkins and her colleagues in CU-Boulder’s department of psychology and neuroscience discovered that a single injection of a compound called ATL313 — an anti-inflammatory drug being developed to treat chronic pain-stopped the progression of MS-caused paralysis in rats for weeks at a time.
Read more: New Multiple Sclerosis Treatment on the Anvil http://www.medindia.net/news/New-Multiple-Sclerosis-Treatment-on-the-Anvil-77030-1.htm#ixzz161BszAUG